Evidence map›Paper›PMID 25476234›Full record

ArticleActa neuropathologica communications2014

Germline mutations in RYR1 are associated with foetal akinesia deformation sequence/lethal multiple pterygium syndrome.

Arthur B McKie, Atif Alsaedi, Julie Vogt, Kyra E Stuurman, Marjan M Weiss, Hassan Shakeel, Louise Tee, Neil V Morgan, Peter G J Nikkels, Gijs van Haaften and 4 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. The Clinical, Histological, and Genetic Spectrum ofJournal of clinical medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Arthur B McKieDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. abm44@medschl.cam.ac.uk.
Atif AlsaediCentre for Rare Diseases and Personalised Medicine, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. ASA195@student.bham.ac.uk.
Julie VogtWest Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, B15 2TG, UK. Julie.Vogt@bwnft.nhs.uk.
Kyra E StuurmanDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. k.stuurman@vumc.nl.
Marjan M WeissDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. j.weiss@vumc.nl.
Hassan ShakeelDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. hs470@cam.ac.uk.
Louise TeeCentre for Rare Diseases and Personalised Medicine, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. L.Tee@bham.ac.uk.
Neil V MorganCentre for Rare Diseases and Personalised Medicine, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. N.V.Morgan@bham.ac.uk.
Peter G J NikkelsDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. P.G.J.Nikkels@umcutrecht.nl.
Gijs van HaaftenDepartment of Medical Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. G.vanHaaften@umcutrecht.nl.
Soo-Mi ParkDepartment of Clinical Genetics, Addenbrooke's Treatment Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. soo-mi.park@addenbrookes.nhs.uk.
Jasper J van der SmagtDepartment of Medical Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. j.j.vandersmagt@umcutrecht.nl.
Marianna BugianiDepartment of Pathology, VU University Medical Center, Amsterdam, the Netherlands. m.bugiani@vumc.nl.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. erm1000@medschl.cam.ac.uk.
Amsterdam UMC Location VUmc · NLUniversity of Birmingham · GBCambridge University Hospitals NHS Foundation Trust · GBUtrecht University · NLBirmingham Women's Hospital · GBNIHR Cambridge Biomedical Research CentreUniversity Medical Center Utrecht · NLUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFoetal akinesia deformation sequence syndrome (FADS) is a genetically heterogeneous disorder characterised by the combination of foetal akinesia and developmental defects which may include pterygia (joint webbing). Traditionally multiple pterygium syndrome (MPS) has been divided into two forms: prenatally lethal (LMPS) and non-lethal Escobar type (EVMPS) types. Interestingly, FADS, LMPS and EVMPS may be allelic e.g. each of these phenotypes may result from mutations in the foetal acetylcholine receptor gamma subunit gene (CHRNG). Many cases of FADS and MPS do not have a mutation in a known FADS/MPS gene and we undertook molecular genetic studies to identify novel causes of these phenotypes.

resultsAfter mapping a novel locus for FADS/LMPS to chromosome 19, we identified a homozygous null mutation in the RYR1 gene in a consanguineous kindred with recurrent LMPS pregnancies. Resequencing of RYR1 in a cohort of 66 unrelated probands with FADS/LMPS/EVMPS (36 with FADS/LMPS and 30 with EVMPS) revealed two additional homozygous mutations (in frame deletions). The overall frequency of RYR1 mutations in probands with FADS/LMPS was 8.3%.

conclusionsOur findings report, for the first time, a homozygous RYR1 null mutation and expand the range of RYR1-related phenotypes to include early lethal FADS/LMPS. We suggest that RYR1 mutation analysis should be performed in cases of severe FADS/LMPS even in the absence of specific histopathological indicators of RYR1-related disease.

Indexed as

Germ-Line MutationAbnormalities, MultipleCodon, NonsenseCohort StudiesDNA Mutational AnalysisFamilyFetusGenetic LinkageHumansMalignant HyperthermiaMicrosatellite RepeatsMuscle, SkeletalRyanodine Receptor Calcium Release ChannelSequence DeletionSkin AbnormalitiesCodon, NonsenseRyanodine Receptor Calcium Release Channel

Identifiers

PMID25476234
PMCPMC4271450
OpenAlexW2160524903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.